Yousra Odeh, Mahmoud Al-Balas
BACKGROUND: Breast cancer treatment has been described as a dynamic and patient-centered approach that emphasizes adaptability and flexibility throughout the treatment process. Breast cancer is complex, with varying subtypes and stages, making it important to tailor treatment plans to each patient's unique circumstances. Breast cancer treatment delivery relies on a multidisciplinary team of health care professionals who collaborate to provide personalized care and quick adaptation to changing conditions to optimize outcomes while minimizing side effects and maintaining the patient's quality of life...
December 5, 2023: JMIR Research Protocols
Stephen Wechsler, Michele Ma, Areej El-Jawahri, Kristen Elizabeth Laws, Haley Naticchioni, Kaitlin Flannery, Alison Coleman, Kathleen Lyons
High rates of employment changes and associated concerns among cancer survivors following diagnosis and treatment suggest a need to examine what employment-related educational resources and support are currently being offered to cancer survivors and what gaps exist in those resources. In 2023, we conducted a content analysis of employment resources described on the websites of the NCI-Designated Cancer Centers that provide clinical care (N = 64) through a systematic review procedure using predetermined search terms and a standardized process to examine the availability and accessibility of such resources...
December 5, 2023: Journal of Cancer Education: the Official Journal of the American Association for Cancer Education
Chia-I Shen, Chi-Lu Chiang, Hsu-Ching Huang, Yen-Han Tseng, Yung-Hung Luo, Huai-Che Yang, Yuh-Min Chen
PURPOSE: ALK-positive NSCLC patients exhibit a particularly high propensity for the development of brain metastases. Current guidelines suggest transit to next-line therapy (SysTx) or local radiotherapy (RadTx) including whole-brain radiotherapy and radiosurgery. However, the clinical impact of these two strategies remains unclear. METHODS: We conducted a retrospective analysis focusing on patients with stage IV ALK-positive NSCLC who underwent first-line ALK TKI treatment...
December 5, 2023: Journal of Neuro-oncology
Shi-Chuan Tang, Yong-Yi Zeng, Tian Yang
No abstract text is available yet for this article.
December 5, 2023: Annals of Surgical Oncology
Manisha B Bhatia, Nicholas Kisilu Muema, Stephen Kiptoo, Ivan Limenik, Emily Adaniya, Silvanus Kibiwot, Lucy Nanjala Wabende, Sally Jepkirui, Dorice Adhiambo Awuor, Jennifer Morgan, Patrick J Loehrer, JoAnna L Hunter-Squires, Naftali Busakhala
No abstract text is available yet for this article.
December 5, 2023: Annals of Surgical Oncology
A Chapman, E Bardsley, H Card, E Marshall, A Olsson-Brown
PURPOSE: In response to a demonstrable need for 24/7, specialist oncology advice for patients undergoing systemic anti-cancer therapy, many healthcare institutions have adopted a telephone triage (TT) service. This is true of the Clatterbridge Cancer Centre which uses the UKONS framework to guide its decisions. This study aims to investigate the utilisation and outcomes of this TT service, with a focus on the most unwell call outcomes and factors leading to referrals to accident and emergency departments that could be mitigated with service development and modifications...
December 5, 2023: Supportive Care in Cancer
Yujun Cui, Xinzhi Liu, Shuai Li, Hongzhi Wang, Yirong Xiang, Yangzi Zhang, Maxiaowei Song, Jianhao Geng, Zhiyan Liu, Huajing Teng, Xianggao Zhu, Yong Cai, Yongheng Li, Weihu Wang
PURPOSE: This study aimed to assess the impact of ypT stage and tumor regression grade (TRG) on the long-term prognosis of patients with locally advanced rectal cancer (LARC) stage ypT1-4N0 after neoadjuvant chemoradiotherapy (NCRT). METHODS: We retrospectively analyzed 585 patients with histologically diagnosed middle-low LARC (cT3-4 or cN + by pelvic MRI) from 2014 to 2019. All patients underwent NCRT, followed by total mesorectal excision. Disease-free survival (DFS) rates were compared among patients with different ypT stages and TRGs by Kaplan-Meier survival analysis...
December 5, 2023: Clinical & Translational Oncology
Deirdre A Shires, Leonardo Kattari, Forrest Hosea, Jen Hirsch, Megan Mulvaney, Alicia K Matthews, Hayley S Thompson
PURPOSE: The purpose of this study was to explore healthcare experiences of Black and White sexual and gender minority (SGM) cancer survivors across the cancer care continuum. METHODS: This was a qualitative analysis of two focus groups and eight individual interviews completed as part of a larger initiative using a community-engaged research approach to reduce cancer disparities in marginalized communities. There was a total of 16 participants in the study (9 were White, 7 were Black) and data were collected between 2019 and 2020...
December 5, 2023: Journal of Cancer Survivorship: Research and Practice
David W Kissane, Irene Bobevski, Jane Appleton, Genevieve Murphy, Anna Laverty-Wilson, Pauley Kessel, Natasha Michael, Richard Chye, Carrie Lethborg
PURPOSE: We aimed to examine the efficacy of Meaning and Purpose (MaP) Therapy in promoting posttraumatic growth and meaningful life attitudes (choices and goal seeking) in people living with advanced cancer. METHODS: Patients with a prognosis ≥ 1 year were stratified across two sites and randomised to receive MaP therapy and regular oncology/palliative care (Intervention) or usual care (Control). They completed measures at baseline (t0), post-intervention (12 weeks, t1) and 12 weeks later (t2)...
November 30, 2023: Supportive Care in Cancer
Elena von Coburg, Sebastian Dunst
Breast cancer is the most common cancer worldwide, with an estimated 2.3 million new cases diagnosed every year. Effective measures for cancer prevention and cancer therapy require a detailed understanding of the individual key disease mechanisms involved and their interactions at the molecular, cellular, tissue, organ, and organism level. In that regard, the rapid progress of biomedical and toxicological research in recent years now allows the pursuit of new approaches based on non-animal methods that provide greater mechanistic insight than traditional animal models and therefore facilitate the development of Adverse Outcome Pathways (AOPs) for human diseases...
December 5, 2023: Discover. Oncology
Samar A Dewidar, Omar Hamdy, Moetaza M Soliman, Amal M El Gayar, Mohamed El-Mesery
Fighting breast tumors mandates finding different agents devoid of chemotherapy side effects. Repurposing existing drugs, such as statins, presents a promising avenue for the development of novel cancer therapeutics. Based on the different effects of statin members, this study aims to evaluate the effect of two of the most promising lipophilic statins, Simvastatin and Pitavastatin, and their combination with a conventional chemotherapeutic regimen of doxorubicin and cyclophosphamide on breast cancer cells. MDA-MB-231 and MCF7 cell lines were used to analyze the effects of Pitavastatin and simvastatin in combination with doxorubicin/cyclophosphamide...
December 5, 2023: Medical Oncology
Valentina Ferri, Emilio Vicente, Yolanda Quijano, Hipolito Duran, Eduardo Diaz, Isabel Fabra, Luis Malave, Pablo Ruiz, Giulia Costantini, Giada Pizzuti, Antonio Cubillo, Maria Carmen Rubio, Lina Garcia Cañamaque, Javier Nuñez Alfonsel, Riccardo Caruso
BACKGROUND: The watch-and-wait (WW) strategy is a potential option for patients with rectal cancer who obtain a complete clinic response after neoadjuvant therapy. The aim of this study is to analyze the long-term oncological outcomes and perform a cost-effectiveness analysis in patients undergoing this strategy for rectal cancer. MATERIAL AND METHODS: The data of patients treated with the WW strategy were prospectively collected from January 2015 to January 2020...
December 5, 2023: International Journal of Colorectal Disease
Samuel Engelsgjerd, Sarah Kodres-O'Brien, Eshrar Choudhury, Belén Mora Garijo, J Bradley Mason, Keith J Kowalczyk
INTRODUCTION: Urethral catheter (UC) discomfort remains a burden following robotic-assisted radical prostatectomy (RARP). Suprapubic catheters (SPC) may reduce patient discomfort and increase satisfaction. Pelvic Fascia Sparing RARP (PFS-RARP) reduces the technical challenges of intra-operative SPC placement. We examined postoperative outcomes of SPC vs UC placement following PFS-RARP. METHODS: We conducted a retrospective review of a prospective IRB-approved database of PFS-RARP patients from June 2020 to December 2022 receiving SPC (n = 108) or UC (n = 104) postoperatively...
December 5, 2023: Urology Practice
Kotaro Higa, Fuminari Uehara, Chinatsu Azuma, Hiromichi Oshiro, Yasunori Tome, Kotaro Nishida
BACKGROUND: Arthroscopic resection of tenosynovial giant cell tumor (TS-GCT) presents favorable outcomes. However, there are reportedly higher recurrence rates in patients who had incomplete resection. To minimize incomplete resection, we established a multiple portal approach depending on the location of the disease. In this study, we aimed to retrospectively evaluate the clinical outcomes of arthroscopic resection for both localized and diffuse types of TS-GCT of the knee. METHODS: From 2009 to 2019, 13 patients who underwent arthroscopic synovectomy of the knee and were histologically diagnosed with TS-GCT were included in this study...
2023: Journal of Orthopaedic Surgery
Sim Yee Tan, Haryana M Dhillon, Channel Mak, Roger Liang, Kim Kerin-Ayres, Kylie Vuong, Ashanya Malalasekera, Janette L Vardy
PURPOSE: Survivorship care plans (SCP) are recommended as integral to survivorship care but are not routinely provided in many centers. We explore whether SCP from the Sydney Cancer Survivorship Centre (SCSC) clinic was received by general practitioners (GP) and cancer specialists, and their views on SCP. METHODS: A mixed-method study comprising a quality assurance audit, a questionnaire of GP practices and GP, and semi-structured interviews of cancer specialists who referred patients to the SCSC clinic between 2019-2020...
December 5, 2023: Asia-Pacific Journal of Clinical Oncology
Ling-Yuk Kuk, Dora Lai-Wan Kwong, Wing-Lok Wendy Chan, Yat-Fung Shea
GPT-4 (Generative Pre-trained Transformer 4) is an AI system with a chat interface. The number of studies testing GPT-4 in clinical applications has been increasing. We hypothesized that GPT-4 would be able to suggest management strategies for medical issues in elderly oncology patients, similar to those provided by geriatricians. We compared the responses of GPT-4 to those of a geriatrician for four oncological patients. After these case conferences, none of the patients required admission for medical consultation...
December 5, 2023: Journal of the Chinese Medical Association: JCMA
Pierre-Maxence Vaysse, Mari F C M van den Hout, Sanne M E Engelen, Kristien B M I Keymeulen, Marc H A Bemelmans, Ron M A Heeren, Steven W M Olde Damink, Tiffany Porta Siegel
BACKGROUND: Soft tissue sarcomas (STS) constitute a heterogeneous group of rare tumor entities. Treatment relies on challenging patient-tailored surgical resection. Real-time intraoperative lipid profiling of electrosurgical vapors by rapid evaporative ionization mass spectrometry (REIMS) may aid in achieving successful surgical R0 resection (i.e., microscopically negative-tumor margin resection). Here, we evaluate the ex vivo accuracy of REIMS to discriminate and identify various STS from normal surrounding tissue...
December 5, 2023: Journal of Surgical Oncology
Ilias Koutsopetras, Valentine Vaur, Rania Benazza, Hélène Diemer, Charlotte Sornay, Yağmur Ersoy, Léa Rochet, Carmen Longo, Oscar Hernandez-Alba, Stéphane Erb, Alexandre Detappe, Arne Skerra, Alain Wagner, Sarah Cianferani, Guilhem Chaubet
The chemical bioconjugation of proteins has seen tremendous applications in the past decades, with the booming of antibody-drug conjugates and their use in oncology. While genetic engineering has permitted to produce bespoke proteins featuring key (un-)natural amino acid residues poised for site-selective modifications, the conjugation of native proteins is riddled with selectivity issues. Chemoselective strategies are plentiful and enable the precise modification of virtually any residue with a reactive side-chain; site-selective methods are less common and usually most effective on small and medium-sized proteins...
December 5, 2023: Chemistry: a European Journal
Mahek Garg, Justin Puckett, Sachin Kamal-Bahl, Monika Raut, Katherine Elizabeth Ryland, Jalpa A Doshi, Scott F Huntington
Aim: To examine real-world treatment patterns, survival, healthcare resource use and costs in elderly Medicare beneficiaries with diffuse large B-cell lymphoma (DLBCL). Methods: 11,880 Medicare patients aged ≥66 years with DLBCL between 1 October 2015 and 31 December 2018 were followed for ≥12 months after initiating front-line treatment. Results: Two-thirds (61.2%) of the patients received standard-of-care R-CHOP as first-line treatment. Hospitalization was common (57%) in the 12-months after initiation of 1L treatment; the mean DLCBL-related total costs were US$84,416 during the same period...
December 5, 2023: Future Oncology
Christina Keny, Ellis C Dillon, Marcia M Russell, Alexis Colley, Veronica Yank, Victoria Tang
OBJECTIVE: This qualitative study aimed to explore the challenges faced by older adults regarding the postoperative symptom experience following major elective surgery. BACKGROUND: Although extensively studied in oncology settings, the impact of postoperative symptom burden remains largely underexplored in elective major surgery among older adults. METHODS: We employed convenience sampling to recruit adults aged ≥65 years undergoing major elective surgery at the University of California, San Francisco...
December 5, 2023: Annals of Surgery
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.